Rising Prevalence Of Neurological Disorders Fuels Growth In The Pharmaceutical Chemicals Market Emerges as a Core Driver of the Pharmaceutical Chemicals Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Is the Expected CAGR for the Pharmaceutical Chemicals Market Through 2025?
The market size of pharmaceutical chemicals has seen significant growth over the past few years. It is anticipated to progress from $138.71 billion in 2024 to $148.39 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. This considerable growth during the historic period is due to factors like drug discovery advancements, an aging population, amendments in regulations, and a rise in chronic diseases.

What's the Projected Size of the Global Pharmaceutical Chemicals Market by 2029?
The market size for pharmaceutical chemicals is anticipated to witness robust growth in the forthcoming years, with a value expected to reach $197.77 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period could be driven by sectors such as personalized medicine, biopharmaceuticals and biosimilars, emerging markets, and advancements in digital health and telemedicine. Moreover, the major trends likely to emerge during the forecast period include precision drug manufacturing, advancements in gene and cell therapies, drug repurposing techniques, and the production and development of vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Top Growth Drivers in the Pharmaceutical Chemicals Industry: What's Accelerating the Market?
The pharmaceutical chemicals market is anticipated to grow due to the increasing incidence of neurological disorders. Neurological disorders, which impact the central and peripheral nervous systems, are conditions that affect the brain, spinal cord, and nerves throughout the body. Pharmaceutical chemicals are crucial in the development of drugs for treating these disorders, managing pain and movement difficulties. For example, as per the 2023 Alzheimer's Disease Facts and Figures report by the Alzheimer's Association, an American voluntary health organization providing Alzheimer's care and support, nearly 6 million Americans are estimated to be suffering from Alzheimer's in 2023, and this number is projected to surge to almost 13 million by 2030. Moreover, the cost of Alzheimer's and other dementias to the nation is expected to be $345 billion in 2023, predicted to escalate to $1 trillion by 2050. These rising occurrences of neurological disorders are driving the growth of the pharmaceutical chemicals market. The growth of the pharmaceutical chemicals market is also expected to be fueled by the expansion of the pharmaceutical industry. The pharmaceutical industry encompasses the research, development, and manufacturing of pharmaceuticals and remedies. Pharmaceutical chemicals, serving as solvents, reagents, catalysts, active substances, and excipients, among other uses, play an integral role in the production of a wide range of pharmaceutical products, including medications, topical ointments, vaccines, dietary supplements, and infant milk formulas. For instance, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry, showed that the total pharmaceutical production in Europe reached $368,832 million (€340,000 million) in 2022, a jump of about 4.95% from $351,420 million (€323,950 million) in 2021. Consequently, the expansion of the pharmaceutical industry is forwarding the growth of the pharmaceutical chemicals market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13013&type=smp

What Trends Will Shape the Pharmaceutical Chemicals Market Through 2029 and Beyond?
Leading pharmaceutical chemical businesses are employing innovative technologies gaining popularity in the pharmaceutical industry, such as software-as-a-service (SaaS) quantum chemistry platforms, to sustain their market share. SaaS Quantum chemistry platforms are cloud-based services offering subscription-based access to quantum chemistry applications and resources. For example, in April 2023, QC Ware Corp, a US-owned firm specializing in quantum computing software, introduced Promethium, a software-as-a-service (SaaS) quantum chemistry platform. The platform is specially designed to expedite discoveries in pharmaceuticals, chemicals, and materials through an advanced quantum chemistry toolkit that utilizes H100 or A100 Tensor Core. The Promethium toolkit can process various chemical systems comprising roughly 100 atoms in mere seconds, compared to the minutes or hours traditional algorithms require.

What Are the Main Segments in the Pharmaceutical Chemicals Market?
The pharmaceutical chemicals market covered in this report is segmented -

1) By Product Type: Solvents, Reagents Or Catalysts, KSMs Or Intermediates, Building Blocks For APIs Or Advanced Intermediates
2) By Drug Type: Proprietary, Non-Proprietary
3) By Application: Cardiovascular Disease, Neurological Disease, Oncological Disease, Respiratory Disease, Gastrointestinal Disease, Musculoskeletal Disease

Subsegments:
1) By Solvents: Organic Solvents, Inorganic Solvents, Aqueous Solvents
2) By Reagents or Catalysts: Organic Reagents, Inorganic Reagents, Biocatalysts
3) By KSMs or Intermediates: Key Starting Materials (KSMs), Pharmaceutical Intermediates
4) By Building Blocks for APIs or Advanced Intermediates: Simple Building Blocks, Complex Building Blocks

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13013&type=smp

Which Top Companies are Driving Growth in the Pharmaceutical Chemicals Market?
Major companies operating in the pharmaceutical chemicals market are BASF SE, The Dow Chemical Company, Abbott Laboratories, Johnson Matthey PLC, Evonik Industries AG, Eastman Chemical Company, Koninklijke DSM N.V, Lanxess AG, Albemarle Corporation, Lonza Group AG, Clariant AG, W. R. Grace and Co, Jubilant Life Sciences Ltd., Sumitomo Seika Chemicals Co Ltd., Borregaard ASA, WeylChem International GmbH, Vertellus Holdings LLC, CABB Group GmbH, Dishman Carbogen Amcis Ltd., Hikal Ltd., Porton Fine Chemicals Ltd., Denisco Chemicals Pvt Ltd., CHEMADA Industries Ltd., Valaji Pharma Chem, Syntor Fine Chemicals Ltd., Kenko Corporation.

Which Regions Will Dominate the Pharmaceutical Chemicals Market Through 2029?
North America was the largest region in the pharmaceutical chemicals market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13013

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.